このアイテムのアクセス数: 103
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
ccr3.4859.pdf | 405.91 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Yamada, Hiroyuki | en |
dc.contributor.author | Ohtsuru, Shigeru | en |
dc.contributor.author | Nagatomo, Mika | en |
dc.contributor.author | Korogi, Yohei | en |
dc.contributor.author | Shinozuka, Ken | en |
dc.contributor.author | Tanabe, Naoya | en |
dc.contributor.author | Kai, Shinichi | en |
dc.contributor.author | Matsubara, Takeshi | en |
dc.contributor.author | Ito, Isao | en |
dc.contributor.author | Ihara, Masahiro | en |
dc.contributor.author | Tanaka, Tomoharu | en |
dc.contributor.author | Kato, Genta | en |
dc.contributor.author | Nagao, Miki | en |
dc.contributor.author | Date, Hiroshi | en |
dc.contributor.alternative | 山田, 博之 | ja |
dc.contributor.alternative | 大鶴, 繁 | ja |
dc.contributor.alternative | 長友, 美佳 | ja |
dc.contributor.alternative | 興梠, 陽平 | ja |
dc.contributor.alternative | 篠塚, 健 | ja |
dc.contributor.alternative | 田辺, 直也 | ja |
dc.contributor.alternative | 甲斐, 慎一 | ja |
dc.contributor.alternative | 松原, 雄 | ja |
dc.contributor.alternative | 伊藤, 功朗 | ja |
dc.contributor.alternative | 井原, 正裕 | ja |
dc.contributor.alternative | 田中, 具治 | ja |
dc.contributor.alternative | 加藤, 源太 | ja |
dc.contributor.alternative | 長尾, 美紀 | ja |
dc.contributor.alternative | 伊達, 洋至 | ja |
dc.date.accessioned | 2022-11-25T05:21:53Z | - |
dc.date.available | 2022-11-25T05:21:53Z | - |
dc.date.issued | 2021-09 | - |
dc.identifier.uri | http://hdl.handle.net/2433/277488 | - |
dc.description.abstract | Extracorporeal membrane oxygenation is indispensable for critically severe COVID-19 patients. However, it would be inapplicable to patients with a rare blood type or blood transfusion refusal. In that case, severely conservative fluid management with the sacrifice of renal functions and hydrocortisone therapy should be considered for better oxygenation. | en |
dc.language.iso | eng | - |
dc.publisher | Wiley | en |
dc.rights | © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. | en |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.subject | AKI | en |
dc.subject | ARDS | en |
dc.subject | COVID-19 | en |
dc.subject | ECMO | en |
dc.subject | hydrocortisone | en |
dc.subject | rhesus | en |
dc.title | Successful treatment of COVID‐19‐related acute respiratory distress syndrome with a rare blood type: A case report | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | Clinical Case Reports | en |
dc.identifier.volume | 9 | - |
dc.identifier.issue | 9 | - |
dc.relation.doi | 10.1002/ccr3.4859 | - |
dc.textversion | publisher | - |
dc.identifier.artnum | e04859 | - |
dc.identifier.pmid | 34594554 | - |
dcterms.accessRights | open access | - |
dc.identifier.eissn | 2050-0904 | - |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス